March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...

Scanning electron microscopy image of an insulin tree-like aggregate. Credit: Wikimedia Commons. For millions of people ...

Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- Awiqli(R) offers adults with type 2 diabetes an alternative to daily basal insulin ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

For more than 100 years, scientists have pursued the idea of insulin in pill form, often described as a "dream" treatment for ...

FDA approves 1st weekly basal insulin, Awiqli, offering adults with Type 2 diabetes a once-weekly injection to improve ...

Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...

Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation ...

Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug ...